What Happened?
Shares of digital medical services platform Teladoc Health (NYSE: TDOC) jumped 3.7% in the afternoon session after the company announced its acquisition of Telecare, an Australian virtual care provider, to expand its international footprint. The strategic acquisition of Telecare, an Australian virtual care provider, bolsters Teladoc's international presence, adding over 300 specialists across 30 specialties to its network. While the company stated the deal, which closed on August 8, is not expected to significantly impact its 2025 financial results, it strengthens its foothold in the Australian market where it has operated for over a decade.
After the initial pop the shares cooled down to $7.59, up 4% from previous close.
Is now the time to buy Teladoc? Access our full analysis report here, it’s free.
What Is The Market Telling Us
Teladoc’s shares are extremely volatile and have had 42 moves greater than 5% over the last year. In that context, today’s move indicates the market considers this news meaningful but not something that would fundamentally change its perception of the business.
The previous big move we wrote about was 2 days ago when the stock gained 8.8% on the news that markets continued to rally as the latest inflation data reinforced expectations for a Federal Reserve rate cut as soon as September. The latest Consumer Price Index (CPI) report for July showed inflation holding steady, reinforcing market expectations that the Federal Reserve could begin cutting interest rates as soon as September. Lower interest rates generally stimulate the economy by making borrowing cheaper for consumers and businesses. This can lead to increased consumer spending and e-commerce activity, which directly benefits online retail and marketplace companies. The positive economic outlook fueled a broad-based rally, pushing the S&P 500 and Nasdaq to new record highs and lifting most growth-oriented technology stocks.
Teladoc is down 20.2% since the beginning of the year, and at $7.59 per share, it is trading 47% below its 52-week high of $14.33 from February 2025. Investors who bought $1,000 worth of Teladoc’s shares 5 years ago would now be looking at an investment worth $37.04.
Today’s young investors won’t have read the timeless lessons in Gorilla Game: Picking Winners In High Technology because it was written more than 20 years ago when Microsoft and Apple were first establishing their supremacy. But if we apply the same principles, then enterprise software stocks leveraging their own generative AI capabilities may well be the Gorillas of the future. So, in that spirit, we are excited to present our Special Free Report on a profitable, fast-growing enterprise software stock that is already riding the automation wave and looking to catch the generative AI next.
